Positron emission tomography for staging of oesophageal and gastroesophageal malignancy.

por Kole, A. C., Plukker, J. T., Nieweg, O. E., Vaalburg, W.
Publicado 1998

The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma.

por Bonfrer, J. M., Korse, C. M., Nieweg, O. E., Rankin, E. M.
Publicado 1998

External validation of a prognostic model to predict survival of patients with sentinel node‐negative melanoma

por Ipenburg, N. A., Nieweg, O. E., Ahmed, T., van Doorn, R., Scolyer, R. A., Long, G. V., Thompson, J. F., Lo, S.
Publicado 2019

Sentinel Node Detection in Head and Neck Malignancies: Innovations in Radioguided Surgery

por Vermeeren, L., Klop, W. M. C., van den Brekel, M. W. M., Balm, A. J. M., Nieweg, O. E., Valdés Olmos, R. A.
Publicado 2009

Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients

por Tanis, P J, Nieweg, O E, Valdés Olmos, R A, Peterse, J L, Rutgers, E J Th, Hoefnagel, C A, Kroon, B B R
Publicado 2002

Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFNα in patients with metastatic melanoma

por de Gast, G C, Batchelor, D, Kersten, M J, Vyth-Dreese, F A, Sein, J, van de Kasteele, W F, Nooijen, W J, Nieweg, O E, Waal, M A de, Boogerd, W
Publicado 2003